For example, in an experiment in which
social responsiveness and decrease polypharmacy burden non-human primates were given oxytocin alone or oxytocin
[143]. Recently, administration of a selective FAAH inhibitor in combination with an opioid antagonist, the combination
resulted in significant improvements in social anxiety over a treatment was found to enhance social attention in a supra-
placebo in a randomized control trial with 149 patients linear manner when compared with oxytocin alone [152].
[145]. However, FAAH inhibitors, CBD and compounds like This provides one example of combining oxytocin with
nabiximols (purified plant extract of 1:1 ratio of CBD and engagement of other signalling networks in order to enhance
DÂ°-THC) have controversial results with mixed evidence of specific effects on social cognition [153].
efficacy in social anxiety and ASD [139,142,143] and may In fact, combination pharmacological approaches are
have different mechanisms of action in brains of patients widely used in psychiatry for depression, anxiety, schizo-
with ASD [146]. In a related line of work, plasma ananda- phrenia and other conditions in cases in which the use of one
mide concentrations were found to be lower in children agent is ineffective [154-157]. In some cases, treatment resist-
with ASD [147]. ance to a pharmacological agent with a particular molecular
In sum, multiple lines of evidence suggest that the endo- mechanism is thought to arise as a result of compensatory
cannabinoid system is important in social development and mechanisms that engage a second molecular mechanism
behaviour across rodents, non-human primates and humans. [158].